¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Other disorders of bone"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • fibrous dysplasia of bone
    »À¼¶À¯Çü¼ºÀÌ»ó
  • flat bone
    ³³ÀÛ»À, ÆíÆò°ñ
  • frontal bone
    À̸¶»À, ÀüµÎ°ñ
  • heel bone
    ¹ß²ÞÄ¡»À, Á¾°ñ
  • herring bone appearance
    û¾î»À¸ð¾ç
  • herring bone artifact
    û¾î»ÀÇã»ó, û¾î»ÀÀΰø¹°
  • hamate bone
    °¥°í¸®»À
  • hammer bone
    ¸ÁÄ¡»À
  • hip bone
    º¼±â»À, °ü°ñ
  • hyoid bone
    ¸ñ»Ô»À, ¼³°ñ
  • irregular bone
    ºÒ±ÔÄ¢»À
  • inlay bone graft
    ¼Ó³Ö±â»ÀÀ̽Ä, ºÀ¹ÚÀÌ»ÀÀ̽Ä, Àη¹À̰ñÀ̽Ä
  • innominate bone
    º¼±â»À, °ü°ñ
  • interwoven bone
    ¾ù°á»À
  • intramedullary bone graft
    ¼ÓÁú³»»ÀÀ̽Ä, °ñ¼ö³»°ñÀ̽Ä
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • cranial bone
    ¸Ó¸®»À, µÎ°³°ñ
  • cuboid bone
    ÀÔ¹æ»À
  • cuneiform bone
    ½û±â»À
  • ethmoid bone
    ¹úÁý»À, »ç°ñ
  • flat bone
    ³³ÀÛ»À
  • frontal bone
    À̸¶»À
  • hamate bone
    °¥°í¸®»À
  • hammer bone
    (¢¡malleus) ¸ÁÄ¡»À
  • heel bone
    (¢¡calcaneus) ¹ß²ÞÄ¡»À
  • hip bone
    º¼±â»À, °ü°ñ
  • hyoid bone
    ¸ñ»Ô»À
  • innominate bone
    (¢¡hip bone) º¼±â»À, °ü°ñ
  • interwoven bone
    ¾ù°á»À
  • irregular bone
    ºÒ±ÔÄ¢»À
  • lacrimal bone
    ´«¹°»À
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • petrous bone
    Ãßü°ñ
  • pisiform bone
    µÎ»ó°ñ(ÔéßÒÍé).
  • pisiform bone
    Äá¾Ë»À
  • pisiform bone
    µÎ»ó°ñ(ÔéßÒÍé).
  • plane bone ³ª os planum
    ÆíÆò°ñ(ø·øÁÍé).
  • pneumatic bone
    °ø±â»À
  • premaxillary bone
    Àü¾Ç°ñ(îñäÉÍé), ÀýÄ¡°ñ(ôîöÍÍé).
  • presentation of anterior parietal bone
    ÀüµÎÁ¤°ñÁ¤À§(îñÔéð¢ÍéïÒêÈ).
  • primary bone
    ÀÏÂ÷»À
  • primary bone development
    ÀÏÂ÷»À¹ß»ý
  • primary bone trabecula
    ÀÏÂ÷»ÀÀܱâµÕ
  • primary sponge bone
    ÀÏÂ÷ÇØ¸é»À
  • primordial bone
    ¿ø½Ã°ñ(ê«ã·Íé).
  • primordial bone marrow cavity
    ¿ø½Ã°ñ¼ö°­ (¡­âÐË·).
  • pubic bone ³ª os pubis
    Ä¡°ñ(ö»Íé).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • topographic localization disorders
  • voice disorders, organic
    ±âÁú(Àû) À½¼ºÀå¾Ö
  • voice disorders, psychogenic
    ½ÉÀÎ(¼º) À½¼ºÀå¾Ö
  • x linked disorders
    X¿¬°ü(XÀÇÁ¸)Àå¾Ö, X¿¬°üÁúº´
  • accessory bone =extra ossicle
    Á¾ÀÚ°ñ(ðúí­Íé), ºÎ°ñ(ÜùÍé), À׿©°ñ(í¥æ®Íé).
  • air bone gap =AB g.
    ±âµµ°ñµµ(û·Â)Â÷
  • alveolar bone
    ÀÌÆ²»À
  • articular surface for cuboid bone
    ÀÔ¹æ°üÀý¸é
  • articular surface for navicular bone
    ¹ß¹è°üÀý¸é
  • aseptic bone necrosis
    ¹«±Õ¼º °ñ ±«»ç(ÙíжàõÍéÎÕÞÝ).
  • astragaloscaphoid bone
    °Å°ñ ÁÖ»ó°ñ(¡­ñÇßÒÍé).
  • audiometry, bone conduction
    °ñµµÃ»·Â û°¢°Ë»ç
  • autogenous bone graft
    ÀÚ°¡°ñ À̽Ä(¼ú)(í»Ê«Íéì¹ãÖâú).
  • autologous bone marrow transplantation
    ÀÚ°¡°ñ¼öÀ̽Ä(¡­ÍéâÐì¹ãÕ).
  • base of metatarsal bone
    ¹ßÇ㸮»À¹Ù´Ú
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Secondary bone
    ÀÌÂ÷»À
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñ
  • Secondary bone trabecula
    ÀÌÂ÷»ÀÀܱâµÕ
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñ¼ÒÁÖ
  • Secondary sponge bone
    ÀÌÂ÷ÇØ¸é»À
    [¿¾ ¿ë¾î] ÀÌÂ÷ÇØ¸é°ñ
  • Alveolar bone
    ÀÌÆ²»À
    [¿¾ ¿ë¾î] Ä¡Á¶°ñ
  • Primary bone
    ÀÏÂ÷»À
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ
  • Primary bone development
    ÀÏÂ÷»À¹ß»ý
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¹ß»ý
  • Primary bone trabecula
    ÀÏÂ÷»ÀÀܱâµÕ
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¼ÒÁÖ
  • Primary sponge bone
    ÀÏÂ÷ÇØ¸é»À
    [¿¾ ¿ë¾î] ÀÏÂ÷ÇØ¸é°ñ
  • Articular surface for cuboid bone
    ÀÔ¹æ°üÀý¸é
    [¿¾ ¿ë¾î] ÀÔ¹æ°ñ°üÀý¸é
  • Palatine bone
    ÀÔõÀå»À
    [¿¾ ¿ë¾î] ±¸°³°ñ
  • Palatine bone
    ÀÔõÀå»À [±¸°³°ñ]
    [¿¾ ¿ë¾î] ±¸°³°ñ
  • Trapezoid bone
    ÀÛÀº¸¶¸§»À
    [¿¾ ¿ë¾î] ¼Ò´ÉÇü°ñ
  • Red bone marrow
    Àû»ö°ñ¼ö [Àû»ö»À¼ÓÁú]
    [¿¾ ¿ë¾î] Àû°ñ¼ö
  • Red bone marrow
    Àû»ö°ñ¼ö [Àû»ö»À¼ÓÁú]
    [¿¾ ¿ë¾î] Àû»ö°ñ¼ö
  • Intermediate cuneiform bone
    Áß°£½û±â»À
    [¿¾ ¿ë¾î] Áß°£¼³»ó°ñ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
OPL other party liability; outer plexiform layer; ovine placental lactogen
ORM orosomucoid; other regulated material; oxygen ratio monitor
OTPS other than personal services
qod every other day [Lat. quaque altera die]
qoh every other hour [Lat. quaque altera hora]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
NMD Neuronal migration disorders
PBD Peroxisome biogenesis disorders
PT-LPDs Post-transplantation lymphoproliferative disorders
PRIME-MD Primary Care Evaluation of Mental Disorders
SADS-L Schedule for Affective Disorders and Schizophrenia Lifetime Version
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • bone reduction procedure
    °ñ Á¦°Å¼ú
  • bone remodeling
    °ñ ÀçÇü¼º
  • bone repair
    °ñ ȸº¹
  • bone resorption
    °ñ Èí¼ö
  • bone saw
    °ñ Åé
  • bone scissors
    °ñ °¡À§
  • bone shaft
    °ñ°£
  • bone spicule
    °ñ ¼Ò±Ø
  • bone structure
    °ñ°Ý, »À ±¸Á¶, °ñ ±¸Á¶
    µ¿¹°ÀÇ ¸öÀ» ÁöÅÊÇϰí üÇüÀ» Çü¼ºÇÏ´Â ±â°ü. ü°Ý ¶Ç´Â ÀÚ¼¼¸¦ ÁöÅÊÇϸç, ¿îµ¿ÀÇ Åä´ë°¡ µÇ°í, ³»ÀåÀÇ ¸ðµç ±â°üÀ» º¸È£ÇÏ´Â ¿ªÇÒÀ» ÇÑ´Ù. ôÃßµ¿¹°¿¡¼­´Â ±âº»ÀûÀ¸·Î °ñ°Ý¿¡ °øÅëÁ¡ÀÌ Àִµ¥, µÎ°ñ°ú ôÃß°¡ Áß½ÉÀ» ÀÌ·ç¸ç, °Å±â¿¡ »çÁö°ñÀÌ À̾îÁø´Ù. µ¿¹°ÀÇ Á¾·ù¿¡ µû¶ó¼­ °ñ°ÝÀÇ Çü»óÀ̳ª ¼ö·® µî¿¡´Â Â÷À̰¡ ÀÖ´Ù. °ñ°ÝÀÇ °áÇÕ ¹æ¹ý¿¡´Â ´ÙÀ½ÀÇ 3Á¾·ù°¡ ÀÖ´Ù. ¨ç °üÀý °áÇÕ : °ñ°ÝÀÇ ´ëºÎºÐÀº °üÀý·Î¼­ ¿òÁ÷À̵µ·Ï µÇ¾î ÀÖ´Ù. ¨è ºÀÇÕ : µÎ°³°ñÀº °ñ°ÝÀÇ °áÇպκÐÀÌ Åé´Ïó·³ µÇ¾î ÀÖ¾î Åé´Ï¹ÙÄû¸¦ ¸ÂÃá µíÀÌ °áÇյǾî ÀÖ´Ù. ¨é ¿¬°ñ °áÇÕ : Á¿ìÀÇ Ä¡°ñÀ̳ª ôÃß°ñ »çÀÌ¿¡´Â ¿¬°ñ Á¶Á÷ÀÌ ÀÖ¾î ±×°ÍÀÌ °ñ°Ý°ú °ñ°ÝÀ» °áÇÕ½ÃŲ´Ù.
  • bone substance
    °ñÁú
  • bone swedging
    °ñ ¾ÐÀÎ
  • bone tissue
    »À Á¶Á÷, °ñ Á¶Á÷
  • bone tuberculosis
    °ñ °áÇÙ
    »À¿¡ ¹ß»ýÇÏ´Â °áÇÙÁõ. ÁÖ·Î Æó °áÇÙ¿¡¼­ 2Â÷ °¨¿°¿¡ ÀÇÇØ Ç÷Ç༺À¸·Î ¹ß»ýÇϰųª, ±ÙÁ¢ Àå±â·ÎºÎÅÍ ¿¬¼ÓÀûÀ¸·Î ħ¹üµÇ¾î ¹ß»ýÇÏ´Â °æ¿ì°¡ ¸¹°í, ¿ø¹ß¼ºÀÎ °ÍÀº µå¹°´Ù. °¡Àå ¸¹ÀÌ ¹ß»ýÇÏ´Â ºÎÀ§´Â Àå°ü »ó°ñÀÇ ´ÜºÎ¿Í Áß°£ºÎÀ̸ç û³â ¹× Àå³âÃþ¿¡ ¸¹´Ù. °ñ¼ö°¡ ħ¹üµÇ¸é °ñ¼ö ¼Ó¿¡ °áÇÙ º´¼Ò¸¦ Çü¼ºÇÏ¿© ÁÖÀ§ÀÇ °ñ Á¶Á÷À» ÆÄ±«ÇÏ°í ¸¶Ä§³»´Â ÇѼº ³ó¾çÀ» ÀÏÀ¸Å²´Ù. °ñ¸·ÀÌ Ä§¹üµÇ¸é °ñ¸éÀ» ħ½ÄÇÏ¿© Ä«¸®¿¡½º
  • bone tumor
    °ñ Á¾¾ç
    óÀ½¿¡ »À¿¡ ¹ß»ýÇÏ´Â Á¾¾ç. ´Ù¸¥ ºÎÀ§¿¡¼­ ¾ÏÀÌ ÀüÀÌÇÏ´Â Àϵµ ÀÖÀ¸³ª, ´ëºÎºÐÀº Á¶°ñ¼¼Æ÷³ª Á¶Á÷ÀÇ ÀÌ»ó Áõ½Ä¿¡ ÀÇÇÏ¿© »ý±ä´Ù. °ñ Á¶Á÷ ÀÚü¿¡¼­ ¹ß»ýÇÏ´Â Á¾¾çÀ¸·Î´Â °ñÁ¾, ¿¬°ñÁ¾ÀÌ ÀÖ°í, »À¿¡ Æ÷ÇÔµÈ °áÇÕÁ¶Á÷¿¡¼­ ¹ß»ýÇÏ´Â ¼¶À¯Á¾, Ç÷°ü¿¡¼­ ¹ß»ýÇÏ´Â Ç÷°üÁ¾, °ñ¼ö¿¡¼­ ¹ß»ýÇÏ´Â °ñ¼öÁ¾ÀÌ ÀÖ´Ù. °ñ¼öÁ¾À» Á¦¿ÜÇϰí´Â ¸ðµÎ ¾ç¼º Á¾¾çÀ¸·Î »ý¸íÀÇ À§ÇèÀÌ µû¸£´Â ÀÏÀº ¾ø°í °ÅÀÇ Å¸°¢ ¼Ò°ß
  • bone turnover
    °ñ ±³Ã¼
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
somatoform disorders Disorders having the presence of physical symptoms that suggest a general medical condition and that are not fully explained by a general medical condition, by the direct effects of a substance, or by another mental disorder. The symptoms must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to factitious disorders and malingering, the physical symptoms are not under voluntary control.
(12 Dec 1998)
speech disorders Long-term disorders in speaking or in perception of speech.
(12 Dec 1998)
necrobiotic disorders A group of disorders characterised by swelling, basophilia, and distortion of collagen bundles in the dermis.
(12 Dec 1998)
neurotic disorders Disorders in which the symptoms are distressing to the individual and recognised by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.
(12 Dec 1998)
stress disorders, posttraumatic Anxiety disorders manifested by the development of characteristic symptoms following a psychologically traumatic event that is outside the normal range of usual human experience. Symptoms include re-experiencing the traumatic event and numbing of responsiveness to or reduced involvement with the external world.
(12 Dec 1998)
substance abuse disorders A class of mental disorders in which behavioural and biological changes are associated with regular use of alcohol, drugs, and related substances that affect the central nervous system and personal and social functioning.
(05 Mar 2000)
substance-induced organic mental disorders Mental disorders caused by use of drugs, e.g., cocaine.
(05 Mar 2000)
substance-related disorders These non-psychotic disorders include those related to the taking of a drug of abuse (including alcohol), to the side effects of a medication, and to toxin exposure.
(12 Dec 1998)
delirium, dementia, amnestic, cognitive disorders Cognitive disorders including delirium, dementia, and other cognitive disorders. These may be the result of substance use, trauma, or other causes.
(12 Dec 1998)
disorders, myeloproliferative Tumours of certain bone marrow cells including those that give rise to red cells, granulocytes, and platelets. As opposed to the lymphoproliferative disorders.
(12 Dec 1998)
dissociative disorders Sudden temporary alterations in the normally integrative functions of consciousness.
(12 Dec 1998)
immunodeficiency disorders <radiology> B-cell (antibody) deficiency: high-grade pathogens: pneumococcus, strep, H. Flu, chronic sinopulmonary disease, usual survival to adulthood, T-cell (cellular) deficiency: low-grade pathogens: fungi, viruses, Pneumocystic, growth retardation, diarrhoea, delayed anergy, short life-span, susceptible to graft vs. Host (GvH) disease, e.g.: DiGeorge syndrome, Nezelhof syndrome Note: increased risk of malignancy
(12 Dec 1998)
immunoproliferative disorders Disorders characterised by abnormal proliferation of primary cells of the immune system or by excessive production of immunoglobulins.
(12 Dec 1998)
impulse control disorders Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.
(12 Dec 1998)
infant nutrition disorders Malnutrition, occurring in infants ages 1 month to 24 months, which is due to insufficient intake of food, dietary nutrients, or a pathophysiologic condition which prevents the absorption and utilization of food. Growth and development are markedly affected.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á